NMRA - neumoratx.com Quarterly Revenue Growth

Symbol and logo of brand Neumora Therapeutics (NMRA)

Neumora Therapeutics (NMRA) is integrating ESG standards into its CNS research by reducing laboratory waste. Quarterly revenue dynamics, with the current level sitting around 0.00, link sustainability with human capital, as a team of top neuroscientists is retained through generous funding. The brand's high authority among physicians and investors is bolstered by a strong development pipeline awaiting final trial results.

NMRA (Neumora Therapeutics Inc) Quarterly Revenue Growth Rate history from 02/21/2024 to 11/20/2026

Summary analytical data breakdowns for Neumora (NMRA)

- cash and cash flow data:
Summary company analysis:Neumora (NMRA)
Manufactured products of Neumora Therapeutics, Inc.

Quarterly revenue growth measures the rate of change in a company's operating income between consecutive periods, reflecting the dynamics of business scaling. A positive trend confirms market expansion, although excessive acceleration may indicate sustainability risks within the model. By analyzing the history of quarterly revenue changes, an investor assesses the effectiveness of the commercialization of developments. For Neumora Therapeutics (NMRA), this indicator complements the transparency of clinical data and confidence in the management's financial reserves.

Main competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Scilex|TVGN (Tevogen Bio) - Sales Change QoQ|Quarterly Sales Growth ACOG (alphacognition.com)|Quarterly Sales Growth Rate Cognition Therapeutics, Inc.|Quarterly Revenue Growth IKT (Inhibikase Pharma)|Quarterly Revenue Growth Cassava Sciences, Inc. SAVA|ASRT - Revenue Growth QoQ|Quarterly Revenue Growth Rate Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Revenue Growth QoQ|OVID - Quarterly Sales Growth Rate|Revenue Growth QoQ Acumen Pharmaceuticals, Inc|Revenue Growth QoQ CRVO|Quarterly Revenue Growth ATHE|Clene - Sales Growth QoQ|Quarterly Revenue Growth PEPG (pepgen.com)|JUNS: Sales Growth QoQ|RLMD - Revenue Growth QoQ|Quarterly Revenue Growth Rate Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ